help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McSheehy, P. M.
Right arrow Articles by Chambers, T. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McSheehy, P. M.
Right arrow Articles by Chambers, T. J.

Endocrinology, Vol 119, 1654-1659, Copyright © 1986 by Endocrine Society

ARTICLES

Osteoblast-like cells in the presence of parathyroid hormone release soluble factor that stimulates osteoclastic bone resorption

PM McSheehy and TJ Chambers

PTH stimulates osteoclastic bone resorption in vivo and in organ culture. We have previously found that if osteoclasts are disaggregated from bone and incubated on bone slices, PTH does not increase bone resorption, but does so if osteoblastic cells are added to the cultures. This suggests that PTH acts primarily on osteoblasts, which are induced by the presence of the hormone to stimulate osteoclastic bone resorption. In the present paper we describe investigations into the mechanism by which osteoblastic cells stimulate osteoclasts. We found that increased resorption could not be accounted for by changes in the bone substrate. Osteoblast-like cells (UMR106) incubated with PTH did, however, release a factor into the culture supernatant that stimulated osteoclastic bone resorption. This factor was stable for at least 7 days when stored at 4 C and survived freeze-thawing, but was inactivated by heating to 65 C for 30 min. Activity was lost entirely after dialysis using a Spectrapor membrane with a mol wt cut-off (MWCO) of 2000. The small size of the molecule was confirmed after ultrafiltration across Amicon filters YM2 and YC05. There was no loss of activity across YM2 (MWCO, 1000), but, in contrast, there was no stimulation in the conditioned medium after ultrafiltration across YC05 (MWCO, 500).


This article has been cited by other articles:


Home page
 Br. J. Sports. Med.Home page
L Maimoun, D Simar, D Malatesta, C Caillaud, E Peruchon, I Couret, M Rossi, and D Mariano-Goulart
Response of bone metabolism related hormones to a single session of strenuous exercise in active elderly subjects
Br. J. Sports Med., August 1, 2005; 39(8): 497 - 502.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
A. Gurlek, M. R. Pittelkow, and R. Kumar
Modulation of Growth Factor/Cytokine Synthesis and Signaling by 1{alpha},25-Dihydroxyvitamin D3: Implications in Cell Growth and Differentiation
Endocr. Rev., December 1, 2002; 23(6): 763 - 786.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
Y. Toba, Y. Kajita, R. Masuyama, Y. Takada, K. Suzuki, and S. Aoe
Dietary Magnesium Supplementation Affects Bone Metabolism and Dynamic Strength of Bone in Ovariectomized Rats
J. Nutr., January 1, 2000; 130(2): 216 - 220.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
T. Kawane and N. Horiuchi
Insulin-Like Growth Factor I Suppresses Parathyroid Hormone (PTH)/PTH-Related Protein Receptor Expression via a Mitogen-Activated Protein Kinase Pathway in UMR-106 Osteoblast-Like Cells
Endocrinology, February 1, 1999; 140(2): 871 - 879.
[Abstract] [Full Text]

Home page
 Physiol. Rev.Home page
G. JONES, S. A. STRUGNELL, and H. F. DeLUCA
Current Understanding of the Molecular Actions of Vitamin D
Physiol Rev, October 1, 1998; 78(4): 1193 - 1231.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
K. Fuller, B. Wong, S. Fox, Y. Choi, and T. J. Chambers
TRANCE Is Necessary and Sufficient for Osteoblast-mediated Activation of Bone Resorption in Osteoclasts
J. Exp. Med., September 7, 1998; 188(5): 997 - 1001.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
B.-Y. Liu, J. Guo, B. Lanske, P. Divieti, H. M. Kronenberg, and F. R. Bringhurst
Conditionally Immortalized Murine Bone Marrow Stromal Cells Mediate Parathyroid Hormone-Dependent Osteoclastogenesis in Vitro
Endocrinology, April 1, 1998; 139(4): 1952 - 1964.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
H. Fleisch
Bisphosphonates: Mechanisms of Action
Endocr. Rev., February 1, 1998; 19(1): 80 - 100.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
T. Nordstrom, L. D. Shrode, O. D. Rotstein, R. Romanek, T. Goto, J. N.M. Heersche, M. F. Manolson, G. F. Brisseau, and S. Grinstein
Chronic Extracellular Acidosis Induces Plasmalemmal Vacuolar Type H+ ATPase Activity in Osteoclasts
J. Biol. Chem., March 7, 1997; 272(10): 6354 - 6360.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
K. A. Hruska and S. L. Teitelbaum
Renal Osteodystrophy
N. Engl. J. Med., July 20, 1995; 333(3): 166 - 175.
[Full Text] [PDF]

Home page
 ScienceHome page
M. Horowitz
Cytokines and estrogen in bone: anti-osteoporotic effects
Science, April 30, 1993; 260(5108): 626 - 627.
[PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1986 by The Endocrine Society